Rosenblum, PhD A, Cruciani, MD, PhD RA, Strain, MD EC, Cleland, PhD CM, Joseph, PhD H, Magura, PhD, CSW S, Marsch, PhD LA, McNicholas, MD, PhD LF, Savage, MD, MS SR, Sundaram, BA A, Portenoy, MD RK. Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: Development and pilot test of a clinical protocol. J of Opioid Management [Internet]. 2012 Nov. 1 [cited 2024 Nov. 24];8(6):369-82. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/22